Avid Radiopharmaceuticals, Inc. to Present at the Inaugural Jefferies Global Life Sciences Conference on June 10th
6/7/2010 4:45:33 PM
PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of products with the potential for earlier and more effective detection, diagnosis and monitoring of brain disorders, today announced that Daniel M. Skovronsky, MD, PhD, Founder and CEO of Avid, will present at the Inaugural Jefferies Global Life Sciences Conference on Thursday, June 10, 2010 at 4:30pm EDT. The conference will be held at The Grand Hyatt Hotel in New York City.
comments powered by